Cancer Immunotherapy Market Size, Share & Trends Report

Cancer Immunotherapy Market Size, Share & Trends Analysis Report, By Product, By Application, By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-693-6
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the cancer immunotherapy market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for cancer immunotherapy market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of cancer immunotherapy market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Cancer Immunotherapy Market Categorization:

The cancer immunotherapy market was categorized into five segments, namely product (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines), application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Ovarian Cancer, Pancreatic Cancer), distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), end-use (Hospitals & Clinics, Cancer Research Centers), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The cancer immunotherapy market was segmented into product, application, distribution, end-use, and region. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The cancer immunotherapy market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Cancer immunotherapy market companies & financials:

The cancer immunotherapy market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • AstraZeneca is a biologics and pharmaceutical company present in over 100 countries. The company has a vast product portfolio, which includes treatment line for respiratory, cardiovascular, gastrointestinal, and neurological conditions. The company is involved in discovery, development, manufacture, and distribution of primary care & specialty care products. AstraZeneca primarily focuses on cardiovascular & metabolic disease, and respiratory, inflammation, autoimmune diseases, and oncology. The company employed 94,442 people worldwide in 2019.

  • Abbott has four core business segments-pharmaceuticals, devices, nutrition, and diagnostics. The company has presence in more than 150 countries with research, manufacturing, sales, and distribution facilities. Abbott’s pharmaceuticals segment offers generic medicines for pain, fever, migraine, inflammation, pancreatic disorders, & hypertension; cardiovascular & metabolic products; and vaccines. The diagnostic segment offers reagents and tests for various applications. The company’s diagnostics portfolio includes technologies, such as polymerase chain reaction, fluorescence in situ hybridization, and DNA & RNA sequencing. Abbott’s immunoassays and clinical chemistry assays are used in the diagnosis of cancer, infectious diseases, cardiovascular diseases, fertility, and therapeutic drug monitoring.

  • Bristol-Myers Squibb (BMS) is a pharmaceutical company that manufactures and sells biopharmaceutical products across the globe. It manufactures products in several therapeutic areas, such as psychiatric disorders, cardiovascular disease, diabetes, HIV/AIDS, hepatitis, cancer, and rheumatoid arthritis and is headquartered in New York. The company was established after the merger of Bristol-Myers and Squibb Corporation. BMS’ R&D center is located in Princeton with other locations in Belgium, India, and Japan.

  • F. Hoffmann-La Roche Ltd is a healthcare company with business operations in pharmaceuticals and diagnostics division. Roche Pharmaceuticals operates as Genentech, Inc. in the U.S. and Chugai Pharmaceutical Co., Ltd. in Japan. It offers products in oncology, infectious diseases, neuroscience, hemophilia, hematology, ophthalmology, respiratory, and immunology field. Roche Diagnostics comprises Roche Professional Diagnostics (RPD), Roche Molecular Diagnostics (RMD), Roche Tissue Diagnostics, and Roche Diabetes Care. The company’s list of clients includes physicians, researchers, laboratories, hospitals, patients, and blood banks. F. Hoffmann-La Roche Ltd operates in over 100 countries and employs 94,442 people worldwide. Strategic mergers & acquisitions make this company one of the leading players in this market.

  • Merck & Co., Inc. is a healthcare solutions provider that operates majorly operates in four segments: pharmaceutical, healthcare services, animal health, and alliances. It offers therapeutic products for asthma, hepatitis C, diabetes, cardiovascular diseases, HIV infections, fungal & intra-abdominal infections, osteoporosis, hypertension, and fertility issues. It also offers animal healthcare products such as anthelmintic products and ointments for acute & chronic otitis. In addition, it also offers products to prevent postoperative nausea & vomiting and for the treatment of metastatic small lung cancer, melanoma, measles, rubella, and chickenpox. The company’s immuno-oncology clinical research program currently involves 700+ trials studying Keytruda across various cancers and treatment settings. The company operates in more than 140 countries.

  • Novartis AG is a Swiss-based multinational company catering to pharmaceutical market. It is also involved in the R&D, manufacturing, and marketing of healthcare products. The company was formed post the merger of Sandoz laboratories and Ciba-Geigy to cater to the agrochemical and pharmaceutical divisions of these firms. It is a publicly held organization with six operating divisions: corporate, Sandoz, consumer (OTC), consumer (animal health), vaccines & diagnostics, Alcon, and pharmaceuticals. The company distributes its products across nearly 155 countries.

  • Pfizer, Inc. is engaged in discovery, development, manufacture, sales, and distribution of medical products across the world. Pfizer’s products range includes medicines, vaccines, and consumer goods. The company offers products for immunology, oncology, diabetes & endocrinology, cardiology, and neurology. Its commercial operations are managed through innovative health and essential health segments. It operates in five sectors, including primary care, oncology, animal & consumer healthcare, emerging economies, and nutrition. The company has 64 manufacturing sites across the globe.

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Cancer Immunotherapy Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2023, historic information from 2018 to 2022, and forecast from 2024 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Cancer Immunotherapy Market Report Assumptions:

  • The report provides market value for the base year 2023 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon